Lutetium177PSMA radionuclide therapy for men with prostate cancer: a review of the current literature and discussion of practical aspects of therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lutetium177PSMA radionuclide therapy for men with prostate cancer: a review of the current literature and discussion of practical aspects of therapy

Published:2017-03 Issue:1 Volume:64 Page:52-60
ISSN:2051-3895
Container-title:Journal of Medical Radiation Sciences
language:en
Short-container-title:J Med Radiat Sci

Author:

Emmett Louise¹²^ORCID,Willowson Kathy³,Violet John⁴,Shin Jane⁵,Blanksby Ashley⁵,Lee Jonathan⁵

Affiliation:

1. University of New South Wales; Sydney NSW Australia

2. Garvan Institute of Medical Research; Darlinghurst Australia

3. Institute of Medical Physics; The University of Sydney; Sydney NSW Australia

4. Peter McCallum Cancer Institute; Melbourne Australia

5. St Vincent's Hospital; Sydney Australia

Publisher

Wiley

Subject

Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Reference42 articles.

1. Therapeutic response and side effects of repeated radioligand therapy with 177Lu-PSMA-DKFZ-617 of castrate-resistant metastatic prostate cancer;Ahmadzadehfar;Oncotarget,2016

2. Radioligand therapy with 177Lu-PSMA-617 of metastatic prostate cancer has already been arrived in clinical use;Ahmadzadehfar;Nucl Med Biol,2016

3. 177Lu-labeled prostate-specific membrane antigen radioligand therapy of metastatic castration-resistant prostate cancer: Safety and efficacy;Baum;J Nucl Med,2016

4. Dosimetry for (177)Lu-DKFZ-PSMA-617: A new radiopharmaceutical for the treatment of metastatic prostate cancer;Delker;Eur J Nucl Med Mol Imaging,2016

5. 177Lu-PSMA-617 therapy, dosimetry and follow-up in patients with metastatic castration-resistant prostate cancer;Fendler;Nuklearmedizin,2016

Cited by 237 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trophic dilution of rare earth elements along the food chain of the Seine estuary (France);Marine Pollution Bulletin;2024-09

2. Prostate-Specific Membrane Antigen-Targeted NIR Phototheranostics for Prostate Cancer;ACS Applied Bio Materials;2024-08-28

3. Immune effects of α and β radionuclides in metastatic prostate cancer;Nature Reviews Urology;2024-08-27

4. Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer;Nature Reviews Urology;2024-08-07

5. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer;European Urology;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3